Skip to main content
. Author manuscript; available in PMC: 2013 Jun 25.
Published in final edited form as: Cytotherapy. 2011 May 4;13(8):976–986. doi: 10.3109/14653249.2011.575356

Table I.

Specificity of CTL lines for IE-1, pp65 and hexon. Three-letter abbreviations represent known epitopes while numbers represent individual peptide pools.

ID HLA pp65 epitope IE-1 epitope Hexon epitope
CMVpos 3 A1, 24; B8, 58 YSE QIK Pool 6
CMVpos 5 A2, 3; B35, 46 Pools 1,2,9,12,15,16 Not Identified Pools 1, 4,7–10
CMVpos 6 A2, 24; B8, 65 NLV VLE Pools 1,3,4,7,11
CMVpos 7 A2, 33; B15, 44 NLV VLE Pools 1,4,7 – 11
CMVpos 8 A2, 29; B7, 44 TPR, RPH, NLV VLA Pool 10
CMVpos 9 A2, 3; B7, 44 TPR, RPH, NLV VLA, KAR Pools 4,6,7,8,11
CMVpos 10 A11, 23; B18, 44 Pools 1–11,13,15,17,19–21 Pools 1–18,20 Not identified
CMVpos 11 A1, 11; B8, 49 YSE Pools 1,2,5,7,19,20 Pools 1,6,11
CMVpos 13 A1, 32; B8, 51 YSE QIK Pools 7,11

A response is defined as positive when the pentamer population is distinct and above negative controls (isotype). A peptide epitope or pool is labeled positive when the spots are 25 or more above background, and 10 or more spots above background in the case of hexon.